| |
| |
|
| Insider
Information: |
Wachter Eric Phd |
| Relationship: |
Chief Technology Offic... |
| City: |
Knoxville |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,714,183 |
|
|
Indirect Shares
|
935,115 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,649,298 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Provectus Biopharmaceuticals Inc |
PVCT |
Chief Technology Offic... |
2016-03-29 |
5,714,183 |
2016-03-29 |
935,115 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-02-07 |
4 |
OE |
$0.75 |
$6,250 |
D/D |
8,333 |
3,776,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2009-07-17 |
4 |
OE |
$1.02 |
$20,400 |
D/D |
20,000 |
2,662,015 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2006-03-31 |
4 |
OE |
$1.10 |
$24,638 |
D/D |
22,398 |
1,774,017 |
|
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Executive VP Pharmaceuticals |
• • – |
2008-06-24 |
4 |
OE |
$1.02 |
$30,600 |
D/D |
30,000 |
2,419,099 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
officerTitle |
• • – |
2006-01-31 |
4 |
OE |
$1.10 |
$43,673 |
D/D |
39,703 |
1,751,619 |
|
- |
|
| PVCT |
Provectus Biopharmaceutic... |
officerTitle |
• • – |
2006-01-04 |
4 |
OE |
$1.10 |
$46,177 |
D/D |
41,979 |
1,711,916 |
|
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2009-04-01 |
4 |
OE |
$0.64 |
$30,000 |
D/D |
46,875 |
2,532,640 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Executive VP Pharmaceuticals |
• • – |
2008-05-30 |
4 |
OE |
$0.62 |
$40,000 |
D/D |
63,281 |
2,389,099 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2008-11-20 |
4 |
OE |
$0.94 |
$62,666 |
D/D |
66,666 |
2,485,765 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2010-07-09 |
4 |
OE |
$1.10 |
$82,500 |
D/D |
75,000 |
3,043,237 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2009-12-22 |
4 |
OE |
$0.94 |
$93,634 |
D/D |
98,334 |
2,810,349 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2008-04-09 |
4 |
OE |
$0.32 |
$39,000 |
D/D |
100,000 |
2,325,818 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2010-09-07 |
4 |
OE |
$1.00 |
$100,000 |
D/D |
100,000 |
3,143,237 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2010-11-19 |
4 |
OE |
$1.00 |
$100,000 |
D/D |
100,000 |
3,243,237 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-04-20 |
4 |
OE |
$1.00 |
$100,000 |
D/D |
100,000 |
4,026,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-05-03 |
4 |
OE |
$1.00 |
$100,000 |
D/D |
100,000 |
4,126,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-07-29 |
4 |
OE |
$1.00 |
$100,000 |
D/D |
100,000 |
4,226,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-09-07 |
4 |
OE |
$0.93 |
$93,000 |
D/D |
100,000 |
4,326,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-10-19 |
4 |
OE |
$0.93 |
$93,000 |
D/D |
100,000 |
4,426,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-11-23 |
4 |
OE |
$0.93 |
$93,000 |
D/D |
100,000 |
4,526,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-12-01 |
4 |
OE |
$0.93 |
$93,000 |
D/D |
100,000 |
4,626,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2011-12-05 |
4 |
OE |
$0.75 |
$75,000 |
D/D |
100,000 |
4,726,570 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Technology Officer |
• • – |
2016-03-29 |
4 |
A |
$1.00 |
$106,000 |
I/I |
106,000 |
930,248 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Vice President Pharmaceuticals |
• • – |
2009-06-08 |
4 |
OE |
$0.64 |
$70,000 |
D/D |
109,375 |
2,642,015 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Technology Officer |
• – – |
2015-12-21 |
4 |
OE |
$1.02 |
$122,400 |
D/D |
120,000 |
5,513,236 |
0 |
- |
|
36 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
